Search results
2 days ago · The financing was co-led by Frazier Life Sciences and Lightspeed Venture Partners, ... About STX-478. STX-478 was designed to improve outcomes in patients harboring PI3Kα mutations, ...
2 days ago · Scorpion plans to use the proceeds from this financing to advance its pipeline of differentiated small molecule oncology programs, in particular, to expand clinical development of its allosteric ...
2 days ago · USA. Published on July 16, 2024. Scorpion Therapeutics, a Boston, MA-based clinical-stage oncology company, raised $150M in Series C funding. The round was led by Frazier Life Sciences and ...
2 days ago · BOSTON– ( BUSINESS WIRE )– Scorpion Therapeutics, Inc ., a pioneering clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision oncology, today announced the closing of a $150 million Series C financing. The financing was co-led by Frazier Life Sciences and Lightspeed ...
1 day ago · Scorpion Therapeutics, a leading oncology company, announced a successful $150 million Series C financing round to advance its precision oncology pipeline. Frazier Life Sciences and Lightspeed Venture Partners co-led the financing, with significant participation from new and existing investors. Scorpion's small molecule discovery engine has generated a robust pipeline, including the promising ...
1 day ago · US oncology specialist Scorpion Therapeutics has closed a $150 million Series C financing. Frazier Life Sciences and Lightspeed Venture Partners co-led the financing, which Scorpion plans to use to advance its pipeline of small molecule oncology programs, in particular, to expand clinical development of its allosteric, differentiated, mutant-selective PI3Kα inhibitor, STX-478.
1 day ago · Scorpion Therapeutics has closed a $150 million series C to support development of its precision oncology pipeline, including lead compound STX-478—a highly specific PI3Kα inhibitor. The financing was co-led by Frazier Life Sciences and Lightspeed Venture Partners and included additional new support from Willett Advisors and leading ...
